{"id":"W4417274515","doi":"","title":"OX40 Ligand Inhibitors for Moderate-to-Severe Atopic Dermatitis: A Review of Phase II Clinical Trial Data.","year":2025,"lang":"en","type":"article","venue":"PubMed","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; Women's College Hospital; University of Toronto","funders":"","keywords":"Clinical trial; Atopic dermatitis; Phases of clinical research; Ligand (biochemistry); Clinical pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001765055,0.0006813857,0.002460127,0.001032444,0.0001705074,0.0009249128,0.0009858077,0.0006752316,0.002854651],"category_scores_gemma":[0.002048755,0.0002130677,0.001411122,0.001404846,0.0002441616,0.0007901472,0.0002853098,0.00106063,0.0006466582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000394079,"about_ca_system_score_gemma":0.000874329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004382277,"about_ca_topic_score_gemma":0.00154641,"domain_scores_codex":[0.9995695,0.0001283617,0.0001181816,0.0000510606,0.0001093672,0.00002354871],"domain_scores_gemma":[0.9985697,0.0008713304,0.0003036438,0.00002229715,0.0001613679,0.00007153408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002127894,0.0001755138,0.0004841959,0.09740514,0.001921267,0.0001774713,0.00006493032,0.0003105624,0.002185641,0.000656745,0.02808515,0.8664055],"study_design_scores_gemma":[0.006482329,0.007575586,0.01239012,0.110448,0.02552991,0.004659988,0.0003038519,0.0006667133,0.002587475,0.002751087,0.826479,0.0001259795],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004268815,0.9985891,0.0000845291,0.0002554718,0.0001275278,0.00003154124,0.00007125576,0.000007149294,0.0004065389],"genre_scores_gemma":[0.003824735,0.9944531,0.0003239136,0.0007089823,0.0001753491,0.00005359854,0.0001421307,0.000004464762,0.0003137517],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002854651,"threshold_uncertainty_score":0.009549737,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08624597568894121,"score_gpt":0.3929683245888637,"score_spread":0.3067223488999224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}